The clinical system of CLL is very heterogeneous, ranging from a reasonably asymptomatic illness that will even regress spontaneously to a progressive disease that eventually contributes to the client’s Demise, so there has often been impressive fascination in deciding the prognosis of particular person patients. Although many prognostic markers